Overview

Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)

Status:
Not yet recruiting

Trial end date:
2021-12-20

Target enrollment:

Participant gender:

Summary

This study aims to assess the pharmacokinetic profile of a Fixed Dose Combination nefopam hydrochloride (30 mg) / paracetamol (500 mg) and individual components taken alone or concomitantly after oral single dose.

Phase:

Phase 1

Details

Lead Sponsor:

Unither Pharmaceuticals, France

Collaborator:

Accutest Research Laboratories (I) Pvt. Ltd.

Treatments:

Acetaminophen
Nefopam